Digg It - Internet and Businesses Online

PPC's are very popular. Once you bid and pay, you start getting traffic to your site. It

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

is a solid strategy as far as traffic generation on demand is concerned. So why do I ad

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ice against its use?

A few reasons...

1) Unless you are a well-funded company, you'll

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ot be able to pay enough to get massive traffic to your site. That's the problem with PP

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

's. And even if you are well-funded, you cut into your profit margins drastically.

2) T

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

he moment you stop paying, you stop getting traffic. You are surely better off with traf

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ic strategies that keep sending your visitors without additional work from you.

3) Your

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

conversion rates can never be as high as those from editorial results and article market

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ng campaigns. The simple reason for this is that people always see those listings as ad

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

vertisements (which they are by the way). And you well know that means that they are the

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e only because they paid not necessarily because they are that good. Editorial results,

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

n the other hand, suggest that there is real value since that is the normal way to get s

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ch positions.

4) Per dollar spent, you get worse results when compared to other techniq

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ues like article marketing. Let me give an example...

If you spend $1000 on bidding an

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

verage of $0.20 per click, you'll get 5,000 visitors and nothing more. However, if you s

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

end the same amount to get 200 articles written for you, you can get up to 500,000 page

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

iews monthly if you post them intelligently on 50 good article directories.

Unless you

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

are a well-funded business and really take time to study how to make the most from PPC's

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

there are more cost effective alternatives.

And, even if you have a huge budget, PPC's

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

should not be your main traffic generation technique because there are better strategies

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/72474/diggit-Why-You-Shouldnt-Use-PPCs-As-Your-Sites-Main-Traffic-Source.html">Why You Shouldn't Use PPC's As Your Site's Main Traffic Source</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/72474/diggit-Why-You-Shouldnt-Use-PPCs-As-Your-Sites-Main-Traffic-Source.html]Why You Shouldn't Use PPC's As Your Site's Main Traffic Source[/url]

In a growing market, new competitors can make a business owner lose his focus. Think more about how to make the pie bigger while maintaining your costs and increasing your profits. When you do your piece of the pie will become bigger.

Are You One Of Those People? A person driven to succeed in Internet marketing by your entrepreneurial spirit. Gets excited by its advantages but haven't considered its disadvantages? Then You Are Probably Destined To Fail!

Tags

Links

Digg It - Why You Shouldn't Use PPC's As Your Site's Main Traffic Source

Related Articles: